Market Share

There are currently two procedures that dominate the female sterilization market; Tubal ligation (laparoscopic) and trans-cervical tubal occlusion. Laparoscopic tubal ligation is the most common form of female sterilization used today. This approach is performed with a laparoscope with a tiny incision in or near the navel to transect, ligate or tie off the fallopian tubes.

A trans-cervical approach is performed by inserting a hysteroscope into the uterine cavity through the vagina. This procedure is the most minimally invasive approach and is now widely accepted by gynecologists for permanent birth control.  Trans-cervical hysteroscopic procedures are ideally performed in a physician based office setting.

Market Share Graph

The Future Female Contraceptive Market

The underlying dynamics occurring in the female contraceptive industry over the last several years have created one of the fastest growing medical technology markets worldwide. Leaders in the female contraceptive industry have created significant value for their shareholders and investors.
 
The female contraceptive market is significant for medical device companies as demonstrated by the successful adoption of trans-cervical hysteroscopic devices on the market. The substantial majority of this growth will be driven as the Next Generation of tubal-occlusion technologies makes access and affordability available to practitioners and women worldwide.

This device is not FDA approved. Not for sale in the U.S.